Global Traveler's Diarrhea Therapeutics Market Growth 2020-2025
According to this study, over the next five years the Traveler's Diarrhea Therapeutics market will register a 7.4%% CAGR in terms of revenue, the global market size will reach $ 945.6 million by 2025, from $ 711.6 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Traveler's Diarrhea Therapeutics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Traveler's Diarrhea Therapeutics market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Traveler's Diarrhea Therapeutics, covering the supply chain analysis, impact assessment to the Traveler's Diarrhea Therapeutics market size growth rate in several scenarios, and the measures to be undertaken by Traveler's Diarrhea Therapeutics companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Adult Traveler's Diarrhea
Children Traveler's Diarrhea
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Salix Pharmaceuticals
P&G
Otsuka Pharma
Valneva
Johnson & Johnson
Livzon
Shanghai United Cell
Immuron
PaxVax
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Traveler's Diarrhea Therapeutics consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Traveler's Diarrhea Therapeutics market by identifying its various subsegments.
Focuses on the key global Traveler's Diarrhea Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Traveler's Diarrhea Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Traveler's Diarrhea Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Traveler's Diarrhea Therapeutics Consumption 2015-2025
2.1.2 Traveler's Diarrhea Therapeutics Consumption CAGR by Region
2.2 Traveler's Diarrhea Therapeutics Segment by Type
2.2.1 Immunization
2.2.2 Non-antibiotic Agents
2.2.3 Antibiotics
2.2.4 Anti-Motility Agents
2.2.5 Others
2.3 Traveler's Diarrhea Therapeutics Consumption by Type
2.3.1 Global Traveler's Diarrhea Therapeutics Consumption Market Share by Type (2015-2020)
2.3.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Type (2015-2020)
2.3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Type (2015-2020)
2.4 Traveler's Diarrhea Therapeutics Segment by Application
2.4.1 Adult Traveler's Diarrhea
2.4.2 Children Traveler's Diarrhea
2.5 Traveler's Diarrhea Therapeutics Consumption by Application
2.5.1 Global Traveler's Diarrhea Therapeutics Consumption Market Share by Type (2015-2020)
2.5.2 Global Traveler's Diarrhea Therapeutics Value and Market Share by Type (2015-2020)
2.5.3 Global Traveler's Diarrhea Therapeutics Sale Price by Type (2015-2020)
3 Global Traveler's Diarrhea Therapeutics by Company
3.1 Global Traveler's Diarrhea Therapeutics Sales Market Share by Company
3.1.1 Global Traveler's Diarrhea Therapeutics Sales by Company (2018-2020)
3.1.2 Global Traveler's Diarrhea Therapeutics Sales Market Share by Company (2018-2020)
3.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company
3.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Company (2018-2020)
3.2.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company (2018-2020)
3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Company
3.4 Global Traveler's Diarrhea Therapeutics Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Traveler's Diarrhea Therapeutics Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Traveler's Diarrhea Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Traveler's Diarrhea Therapeutics by Regions
4.1 Traveler's Diarrhea Therapeutics by Regions
4.2 Americas Traveler's Diarrhea Therapeutics Consumption Growth
4.3 APAC Traveler's Diarrhea Therapeutics Consumption Growth
4.4 Europe Traveler's Diarrhea Therapeutics Consumption Growth
4.5 Middle East & Africa Traveler's Diarrhea Therapeutics Consumption Growth
5 Americas
5.1 Americas Traveler's Diarrhea Therapeutics Consumption by Countries
5.1.1 Americas Traveler's Diarrhea Therapeutics Consumption by Countries (2015-2020)
5.1.2 Americas Traveler's Diarrhea Therapeutics Value by Countries (2015-2020)
5.2 Americas Traveler's Diarrhea Therapeutics Consumption by Type
5.3 Americas Traveler's Diarrhea Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Traveler's Diarrhea Therapeutics Consumption by Regions
6.1.1 APAC Traveler's Diarrhea Therapeutics Consumption by Regions (2015-2020)
6.1.2 APAC Traveler's Diarrhea Therapeutics Value by Regions (2015-2020)
6.2 APAC Traveler's Diarrhea Therapeutics Consumption by Type
6.3 APAC Traveler's Diarrhea Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Traveler's Diarrhea Therapeutics by Countries
7.1.1 Europe Traveler's Diarrhea Therapeutics Consumption by Countries (2015-2020)
7.1.2 Europe Traveler's Diarrhea Therapeutics Value by Countries (2015-2020)
7.2 Europe Traveler's Diarrhea Therapeutics Consumption by Type
7.3 Europe Traveler's Diarrhea Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Traveler's Diarrhea Therapeutics by Countries
8.1.1 Middle East & Africa Traveler's Diarrhea Therapeutics Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Traveler's Diarrhea Therapeutics Value by Countries (2015-2020)
8.2 Middle East & Africa Traveler's Diarrhea Therapeutics Consumption by Type
8.3 Middle East & Africa Traveler's Diarrhea Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Traveler's Diarrhea Therapeutics Distributors
10.3 Traveler's Diarrhea Therapeutics Customer
11 Global Traveler's Diarrhea Therapeutics Market Forecast
11.1 Global Traveler's Diarrhea Therapeutics Consumption Forecast (2021-2025)
11.2 Global Traveler's Diarrhea Therapeutics Forecast by Regions
11.2.1 Global Traveler's Diarrhea Therapeutics Forecast by Regions (2021-2025)
11.2.2 Global Traveler's Diarrhea Therapeutics Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Traveler's Diarrhea Therapeutics Forecast by Type
11.8 Global Traveler's Diarrhea Therapeutics Forecast by Application
12 Key Players Analysis
12.1 Salix Pharmaceuticals
12.1.1 Company Information
12.1.2 Traveler's Diarrhea Therapeutics Product Offered
12.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Salix Pharmaceuticals Latest Developments
12.2 P&G
12.2.1 Company Information
12.2.2 Traveler's Diarrhea Therapeutics Product Offered
12.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 P&G Latest Developments
12.3 Otsuka Pharma
12.3.1 Company Information
12.3.2 Traveler's Diarrhea Therapeutics Product Offered
12.3.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Otsuka Pharma Latest Developments
12.4 Valneva
12.4.1 Company Information
12.4.2 Traveler's Diarrhea Therapeutics Product Offered
12.4.3 Valneva Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Valneva Latest Developments
12.5 Johnson & Johnson
12.5.1 Company Information
12.5.2 Traveler's Diarrhea Therapeutics Product Offered
12.5.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Johnson & Johnson Latest Developments
12.6 Livzon
12.6.1 Company Information
12.6.2 Traveler's Diarrhea Therapeutics Product Offered
12.6.3 Livzon Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Livzon Latest Developments
12.7 Shanghai United Cell
12.7.1 Company Information
12.7.2 Traveler's Diarrhea Therapeutics Product Offered
12.7.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Shanghai United Cell Latest Developments
12.8 Immuron
12.8.1 Company Information
12.8.2 Traveler's Diarrhea Therapeutics Product Offered
12.8.3 Immuron Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Immuron Latest Developments
12.9 PaxVax
12.9.1 Company Information
12.9.2 Traveler's Diarrhea Therapeutics Product Offered
12.9.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 PaxVax Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Traveler's Diarrhea Therapeutics Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Immunization
Table 5. Major Players of Non-antibiotic Agents
Table 6. Major Players of Antibiotics
Table 7. Major Players of Anti-Motility Agents
Table 8. Major Players of Others
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Traveler's Diarrhea Therapeutics Consumption Market Share by Type (2015-2020)
Table 11. Global Traveler's Diarrhea Therapeutics Revenue by Type (2015-2020) ($ million)
Table 12. Global Traveler's Diarrhea Therapeutics Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Traveler's Diarrhea Therapeutics Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Traveler's Diarrhea Therapeutics Consumption Market Share by Application (2015-2020)
Table 16. Global Traveler's Diarrhea Therapeutics Value by Application (2015-2020)
Table 17. Global Traveler's Diarrhea Therapeutics Value Market Share by Application (2015-2020)
Table 18. Global Traveler's Diarrhea Therapeutics Sale Price by Application (2015-2020)
Table 19. Global Traveler's Diarrhea Therapeutics Sales by Company (2017-2019) (K Units)
Table 20. Global Traveler's Diarrhea Therapeutics Sales Market Share by Company (2017-2019)
Table 21. Global Traveler's Diarrhea Therapeutics Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company (2017-2019)
Table 23. Global Traveler's Diarrhea Therapeutics Sale Price by Company (2017-2019)
Table 24. Global Traveler's Diarrhea Therapeutics Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Traveler's Diarrhea Therapeutics Products Offered
Table 26. Traveler's Diarrhea Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Traveler's Diarrhea Therapeutics Consumption by Regions 2015-2020 (K Units)
Table 28. Global Traveler's Diarrhea Therapeutics Consumption Market Share by Regions 2015-2020
Table 29. Global Traveler's Diarrhea Therapeutics Value by Regions 2015-2020 ($ Millions)
Table 30. Global Traveler's Diarrhea Therapeutics Value Market Share by Regions 2015-2020
Table 31. Americas Traveler's Diarrhea Therapeutics Consumption by Countries (2015-2020) (K Units)
Table 32. Americas Traveler's Diarrhea Therapeutics Consumption Market Share by Countries (2015-2020)
Table 33. Americas Traveler's Diarrhea Therapeutics Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Traveler's Diarrhea Therapeutics Value Market Share by Countries (2015-2020)
Table 35. Americas Traveler's Diarrhea Therapeutics Consumption by Type (2015-2020) (K Units)
Table 36. Americas Traveler's Diarrhea Therapeutics Consumption Market Share by Type (2015-2020)
Table 37. Americas Traveler's Diarrhea Therapeutics Consumption by Application (2015-2020) (K Units)
Table 38. Americas Traveler's Diarrhea Therapeutics Consumption Market Share by Application (2015-2020)
Table 39. APAC Traveler's Diarrhea Therapeutics Consumption by Countries (2015-2020) (K Units)
Table 40. APAC Traveler's Diarrhea Therapeutics Consumption Market Share by Countries (2015-2020)
Table 41. APAC Traveler's Diarrhea Therapeutics Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Traveler's Diarrhea Therapeutics Value Market Share by Regions (2015-2020)
Table 43. APAC Traveler's Diarrhea Therapeutics Consumption by Type (2015-2020) (K Units)
Table 44. APAC Traveler's Diarrhea Therapeutics Consumption Market Share by Type (2015-2020)
Table 45. APAC Traveler's Diarrhea Therapeutics Consumption by Application (2015-2020) (K Units)
Table 46. APAC Traveler's Diarrhea Therapeutics Consumption Market Share by Application (2015-2020)
Table 47. Europe Traveler's Diarrhea Therapeutics Consumption by Countries (2015-2020) (K Units)
Table 48. Europe Traveler's Diarrhea Therapeutics Consumption Market Share by Countries (2015-2020)
Table 49. Europe Traveler's Diarrhea Therapeutics Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Traveler's Diarrhea Therapeutics Value Market Share by Countries (2015-2020)
Table 51. Europe Traveler's Diarrhea Therapeutics Consumption by Type (2015-2020) (K Units)
Table 52. Europe Traveler's Diarrhea Therapeutics Consumption Market Share by Type (2015-2020)
Table 53. Europe Traveler's Diarrhea Therapeutics Consumption by Application (2015-2020) (K Units)
Table 54. Europe Traveler's Diarrhea Therapeutics Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Traveler's Diarrhea Therapeutics Consumption by Countries (2015-2020) (K Units)
Table 56. Middle East & Africa Traveler's Diarrhea Therapeutics Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Traveler's Diarrhea Therapeutics Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Traveler's Diarrhea Therapeutics Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Traveler's Diarrhea Therapeutics Consumption by Type (2015-2020) (K Units)
Table 60. Middle East & Africa Traveler's Diarrhea Therapeutics Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Traveler's Diarrhea Therapeutics Consumption by Application (2015-2020) (K Units)
Table 62. Middle East & Africa Traveler's Diarrhea Therapeutics Consumption Market Share by Application (2015-2020)
Table 63. Traveler's Diarrhea Therapeutics Distributors List
Table 64. Traveler's Diarrhea Therapeutics Customer List
Table 65. Global Traveler's Diarrhea Therapeutics Consumption Forecast by Countries (2021-2025) (K Units)
Table 66. Global Traveler's Diarrhea Therapeutics Consumption Market Forecast by Regions
Table 67. Global Traveler's Diarrhea Therapeutics Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Traveler's Diarrhea Therapeutics Value Market Share Forecast by Regions
Table 69. Global Traveler's Diarrhea Therapeutics Consumption Forecast by Type (2021-2025) (K Units)
Table 70. Global Traveler's Diarrhea Therapeutics Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Traveler's Diarrhea Therapeutics Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Traveler's Diarrhea Therapeutics Value Market Share Forecast by Type (2021-2025)
Table 73. Global Traveler's Diarrhea Therapeutics Consumption Forecast by Application (2021-2025) (K Units)
Table 74. Global Traveler's Diarrhea Therapeutics Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Traveler's Diarrhea Therapeutics Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Traveler's Diarrhea Therapeutics Value Market Share Forecast by Application (2021-2025)
Table 77. Salix Pharmaceuticals Product Offered
Table 78. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 79. Salix Pharmaceuticals Main Business
Table 80. Salix Pharmaceuticals Latest Developments
Table 81. Salix Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 82. P&G Product Offered
Table 83. P&G Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 84. P&G Main Business
Table 85. P&G Latest Developments
Table 86. P&G Basic Information, Company Total Revenue (in $ million), Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 87. Otsuka Pharma Product Offered
Table 88. Otsuka Pharma Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 89. Otsuka Pharma Main Business
Table 90. Otsuka Pharma Latest Developments
Table 91. Otsuka Pharma Basic Information, Company Total Revenue (in $ million), Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 92. Valneva Product Offered
Table 93. Valneva Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 94. Valneva Main Business
Table 95. Valneva Latest Developments
Table 96. Valneva Basic Information, Company Total Revenue (in $ million), Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 97. Johnson & Johnson Product Offered
Table 98. Johnson & Johnson Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 99. Johnson & Johnson Main Business
Table 100. Johnson & Johnson Latest Developments
Table 101. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 102. Livzon Product Offered
Table 103. Livzon Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 104. Livzon Main Business
Table 105. Livzon Latest Developments
Table 106. Livzon Basic Information, Company Total Revenue (in $ million), Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 107. Shanghai United Cell Product Offered
Table 108. Shanghai United Cell Basic Information, Company Total Revenue (in $ million), Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 109. Shanghai United Cell Main Business
Table 110. Shanghai United Cell Latest Developments
Table 111. Shanghai United Cell Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. Immuron Product Offered
Table 113. Immuron Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 114. Immuron Main Business
Table 115. Immuron Latest Developments
Table 116. Immuron Basic Information, Company Total Revenue (in $ million), Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 117. PaxVax Product Offered
Table 118. PaxVax Traveler's Diarrhea Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 119. PaxVax Main Business
Table 120. PaxVax Latest Developments
Table 121. PaxVax Basic Information, Company Total Revenue (in $ million), Traveler's Diarrhea Therapeutics Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Traveler's Diarrhea Therapeutics
Figure 2. Traveler's Diarrhea Therapeutics Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Traveler's Diarrhea Therapeutics Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Traveler's Diarrhea Therapeutics Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Immunization
Figure 7. Product Picture of Non-antibiotic Agents
Figure 8. Product Picture of Antibiotics
Figure 9. Product Picture of Anti-Motility Agents
Figure 10. Product Picture of Others
Figure 11. Global Traveler's Diarrhea Therapeutics Consumption Market Share by Type (2015-2020)
Figure 12. Global Traveler's Diarrhea Therapeutics Value Market Share by Type (2015-2020)
Figure 13. Traveler's Diarrhea Therapeutics Consumed in Adult Traveler's Diarrhea
Figure 14. Global Traveler's Diarrhea Therapeutics Market: Adult Traveler's Diarrhea (2015-2020) (K Units)
Figure 15. Global Traveler's Diarrhea Therapeutics Market: Adult Traveler's Diarrhea (2015-2020) ($ Millions)
Figure 16. Traveler's Diarrhea Therapeutics Consumed in Children Traveler's Diarrhea
Figure 17. Global Traveler's Diarrhea Therapeutics Market: Children Traveler's Diarrhea (2015-2020) (K Units)
Figure 18. Global Traveler's Diarrhea Therapeutics Market: Children Traveler's Diarrhea (2015-2020) ($ Millions)
Figure 19. Global Traveler's Diarrhea Therapeutics Consumption Market Share by Application (2015-2020)
Figure 20. Global Traveler's Diarrhea Therapeutics Value Market Share by Application (2015-2020)
Figure 21. Global Traveler's Diarrhea Therapeutics Sales Market Share by Company in 2017
Figure 22. Global Traveler's Diarrhea Therapeutics Sales Market Share by Company in 2019
Figure 23. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company in 2017
Figure 24. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company in 2019
Figure 25. Global Traveler's Diarrhea Therapeutics Sale Price by Company in 2019
Figure 26. Global Traveler's Diarrhea Therapeutics Consumption Market Share by Regions 2015-2020
Figure 27. Global Traveler's Diarrhea Therapeutics Value Market Share by Regions 2015-2020
Figure 28. Americas Traveler's Diarrhea Therapeutics Consumption 2015-2020 (K Units)
Figure 29. Americas Traveler's Diarrhea Therapeutics Value 2015-2020 ($ Millions)
Figure 30. APAC Traveler's Diarrhea Therapeutics Consumption 2015-2020 (K Units)
Figure 31. APAC Traveler's Diarrhea Therapeutics Value 2015-2020 ($ Millions)
Figure 32. Europe Traveler's Diarrhea Therapeutics Consumption 2015-2020 (K Units)
Figure 33. Europe Traveler's Diarrhea Therapeutics Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Traveler's Diarrhea Therapeutics Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Traveler's Diarrhea Therapeutics Value 2015-2020 ($ Millions)
Figure 36. Americas Traveler's Diarrhea Therapeutics Consumption Market Share by Countries in 2019
Figure 37. Americas Traveler's Diarrhea Therapeutics Value Market Share by Countries in 2019
Figure 38. Americas Traveler's Diarrhea Therapeutics Consumption Market Share by Type in 2019
Figure 39. Americas Traveler's Diarrhea Therapeutics Consumption Market Share by Application in 2019
Figure 40. United States Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 41. United States Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Traveler's Diarrhea Therapeutics Consumption Market Share by Countries in 2019
Figure 47. APAC Traveler's Diarrhea Therapeutics Value Market Share by Regions in 2019
Figure 48. APAC Traveler's Diarrhea Therapeutics Consumption Market Share by Type in 2019
Figure 49. APAC Traveler's Diarrhea Therapeutics Consumption Market Share by Application in 2019
Figure 50. China Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 51. China Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 58. India Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 59. India Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Traveler's Diarrhea Therapeutics Consumption Market Share by Countries in 2019
Figure 63. Europe Traveler's Diarrhea Therapeutics Value Market Share by Countries in 2019
Figure 64. Europe Traveler's Diarrhea Therapeutics Consumption Market Share by Type in 2019
Figure 65. Europe Traveler's Diarrhea Therapeutics Consumption Market Share by Application in 2019
Figure 66. Germany Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 68. France Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 69. France Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 70. UK Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 71. UK Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Traveler's Diarrhea Therapeutics Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Traveler's Diarrhea Therapeutics Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Traveler's Diarrhea Therapeutics Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Traveler's Diarrhea Therapeutics Consumption Market Share by Application in 2019
Figure 80. Egypt Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Traveler's Diarrhea Therapeutics Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Traveler's Diarrhea Therapeutics Value Growth 2015-2020 ($ Millions)
Figure 90. Global Traveler's Diarrhea Therapeutics Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Traveler's Diarrhea Therapeutics Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 93. Americas Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 94. APAC Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 95. APAC Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 96. Europe Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 97. Europe Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 100. United States Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 101. United States Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 102. Canada Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 103. Canada Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 104. Mexico Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 105. Mexico Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 106. Brazil Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 107. Brazil Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 108. China Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 109. China Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 110. Japan Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 111. Japan Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 112. Korea Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 113. Korea Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 116. India Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 117. India Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 118. Australia Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 119. Australia Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 120. Germany Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 121. Germany Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 122. France Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 123. France Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 124. UK Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 125. UK Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 126. Italy Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 127. Italy Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 128. Russia Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 129. Russia Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 130. Spain Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 131. Spain Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 132. Egypt Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 133. Egypt Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 134. South Africa Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 135. South Africa Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 136. Israel Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 137. Israel Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 138. Turkey Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 139. Turkey Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Traveler's Diarrhea Therapeutics Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Traveler's Diarrhea Therapeutics Value 2021-2025 ($ Millions)
Figure 142. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Market Share (2018-2020)
Figure 143. P&G Traveler's Diarrhea Therapeutics Market Share (2018-2020)
Figure 144. Otsuka Pharma Traveler's Diarrhea Therapeutics Market Share (2018-2020)
Figure 145. Valneva Traveler's Diarrhea Therapeutics Market Share (2018-2020)
Figure 146. Johnson & Johnson Traveler's Diarrhea Therapeutics Market Share (2018-2020)
Figure 147. Livzon Traveler's Diarrhea Therapeutics Market Share (2018-2020)
Figure 148. Shanghai United Cell Traveler's Diarrhea Therapeutics Market Share (2018-2020)
Figure 149. Immuron Traveler's Diarrhea Therapeutics Market Share (2018-2020)
Figure 150. PaxVax Traveler's Diarrhea Therapeutics Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets